TP53 and neoplasm: For example, in multistep cell models of 34 cancer cell lines derived from 23 HGSOC patients to develop new treatments for therapy, it is demonstrated that loss of TP53 wild type is the main driving force of tumorigenesis and tumor progression in HGSOC.[156] Cancer cell line models can be applied for clinical therapeutic targets in multistep tumor progression.